Johnson & Johnson: Mania trials
The registry lists 15 Mania studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 3 15(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I DisorderCompletedNCT00490971Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I DisorderCompletedNCT00309699Phase 3
- A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I DisorderCompletedNCT00309686Phase 3
- A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I DisorderCompletedNCT00299715Phase 3
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I DisorderCompletedNCT00257075Phase 3
- A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With HaloperidolCompletedNCT00253162Phase 3
- A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar DisorderCompletedNCT00253149Phase 3
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.CompletedNCT00250367Phase 3
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I DisorderCompletedNCT00249236Phase 3
- A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar DisorderCompletedNCT00240721Phase 3
- Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient SettingCompletedNCT00237289Phase 3
- Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and AdolescentsCompletedNCT00076115Phase 3
- A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I DisorderCompletedNCT00037674Phase 3
- A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I DisorderCompletedNCT00035802Phase 3
- A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I DisorderCompletedNCT00035230Phase 3